In recent times, there has been an increasing trend in the use of direct oral anticoagulants (DOACs) such as direct factor Xa inhibitors which includes apixaban, rivaroxaban, and edoxaban, or direct thrombin inhibitors such as dabigatran.
← all excerpts
Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.
1
—
—